Products

LiverMultiScan
Perspectum
Gastroenterology AI
LiverMultiScan by Perspectum is an FDA-cleared, non-invasive MRI-based AI tool that quantifies liver fat, iron, inflammation, and fibrosis to aid in the diagnosis and management of chronic liver diseases.
Hepatica v1
Perspectum
Oncology AI
Hepatica v1 by Perspectum is an AI-driven clinical and surgical decision support tool that provides quantitative measurements and visualizations of liver health from MRI data, primarily for pre-surgical planning in liver cancer.
MRCP+
Perspectum
Gastroenterology AI
MRCP+ by Perspectum Diagnostics is an AI-powered advanced biliary visualization software that enhances MRCP images to provide quantitative assessment and improved 3D visualization of the biliary tree and pancreatic duct, aiding in the diagnosis and monitoring of pancreatobiliary diseases like Primary Sclerosing Cholangitis (PSC).

See all 4 products →

About Perspectum

Perspectum is a precision health company that leverages artificial intelligence (AI) and advanced medical imaging to provide non-invasive solutions for the diagnosis, monitoring, and management of chronic diseases. Their technology extracts quantitative biomarkers from MRI scans, offering a more comprehensive and objective assessment of organ health compared to conventional diagnostics. For physicians, this means access to detailed, multi-dimensional insights that can aid in earlier disease detection, more informed clinical decision-making, and the development of personalized treatment plans.

The company’s flagship product, LiverMultiScan, is an FDA-cleared software that utilizes multiparametric MRI to quantify liver fat, and correlates of iron, fibrosis, and inflammation across the entire liver. This technology has the potential to reduce the need for invasive and risky liver biopsies, providing a sensitive diagnostic tool that assesses the whole organ. Perspectum also offers CoverScan, a multi-organ MRI technology, and MRCP+, with their solutions delivered through a cloud-based SaaS platform called the Perspectum Portal, enabling global deployment and standardized data processing. Their work extends to supporting pharmaceutical companies in drug development by providing companion diagnostics and biomarkers for conditions such as NASH, viral hepatitis, liver cancer, autoimmune diseases, and cardiometabolic conditions.

Focus Areas

precision medicine medical imaging AI-driven diagnostics metabolic diseases liver conditions diabetes cancer multi-organ assessment cardiometabolic disease

Business Intelligence

Technologycloud-based software-as-a-service (SaaS) platform, AI algorithms, multiparametric MRI analysis, proprietary biomarkers

What Physicians Need to Know

Metabolic Diseases & Diabetes
Perspectum offers multi-organ services through quantitative MRI and DXA to support clinical trials for obesity, metabolic, and neuromuscular diseases. Their Atlas metabolic software suite aims to improve outcomes by providing various measures of organ health.
Liver Conditions (NAFLD, NASH, PSC, AIH)
Perspectum is renowned for its advanced imaging technology, particularly LiverMultiScan, which provides detailed insights into liver health non-invasively, assessing liver fat, fibrosis, and inflammation. Their iron-corrected T1 (cT1) biomarker is patented for assessing NAFLD and NASH. They also offer quantitative biliary system imaging with MRCP+.
Cancer
Perspectum provides integrated analysis using non-invasive multi-organ and tumor characterization software, digital pathology, and endoscopy for deeper, rapid analysis of cancer patients. Their advanced 3D medical imaging software revolutionizes oncology trials with improved standardization, reproducibility, quantitative organ health metrics, and tumor burden metrics.
Multi-organ Health & Long COVID
Perspectum's CoverScan is a non-invasive imaging tool that assesses the health of six organs in a single scan, developed to evaluate multi-organ impairment in patients with Long COVID and other conditions. They also offer a multi-organ MRI assessment platform to identify multi-organ impairment.
Quantitative MRI & AI-driven Diagnostics
Perspectum specializes in medical imaging software, AI-powered diagnostics, and quantitative biomarkers, developing non-invasive tools that analyze MRI and other clinical images. Their proprietary technology extracts biomarkers from imaging in an intuitive and streamlined way, leading to better diagnoses and outcomes.
Contract Research Organization (CRO) Solutions
Perspectum offers proprietary biomarkers for identifying and monitoring disease in clinical trials, delivered as a turn-key medical imaging solution via a secure, cloud-based SaaS. They support clinical trials with customizable imaging protocols and central read workflows for non-invasive quantification of organ health.
Physician Tip

Perspectum's solutions provide physicians with safe, streamlined, and accessible advanced imaging that offers comprehensive diagnostics and helps understand complex data for precision care. Their non-invasive technology, such as LiverMultiScan, has the potential to replace invasive procedures like liver biopsies, offering a sensitive diagnostic for the whole liver and reducing patient risk and pain. The clear, clinician-ready reports from their multi-organ assessments support faster diagnosis, personalized treatment, and improved patient engagement. Furthermore, their technology can aid in early detection and management of chronic diseases, including predicting disease progression.

Perspectum's technology leverages existing MRI hardware and utilizes a secure, cloud-based service for centralized, standardized data processing. Their cloud-based imaging analytics and reporting portal facilitates the delivery, review, and distribution of MRI-derived analytics and diagnostic reports. They also offer research collaboration and clinical study support, including participation in multi-center trials and biomarker evaluation.

Products by Perspectum

4 products in the directory

LiverMultiScan
Perspectum
Gastroenterology AI
LiverMultiScan by Perspectum is an FDA-cleared, non-invasive MRI-based AI tool that quantifies liver fat, iron, inflammation, and fibrosis to aid in the diagnosis and management of chronic liver diseases.
Hepatica v1
Perspectum
Oncology AI
Hepatica v1 by Perspectum is an AI-driven clinical and surgical decision support tool that provides quantitative measurements and visualizations of liver health from MRI data, primarily for pre-surgical planning in liver cancer.
MRCP+
Perspectum
Gastroenterology AI
MRCP+ by Perspectum Diagnostics is an AI-powered advanced biliary visualization software that enhances MRCP images to provide quantitative assessment and improved 3D visualization of the biliary tree and pancreatic duct, aiding in the diagnosis and monitoring of pancreatobiliary diseases like Primary Sclerosing Cholangitis (PSC).
LiverMultiScan v5
Perspectum
Gastroenterology AI
LiverMultiScan v5 is an AI-powered, non-invasive MRI-based software that quantifies liver fat, iron, and fibroinflammation (cT1) to aid in the diagnosis and monitoring of chronic liver diseases.

What the Web Says

Perspectum is an Oxford-based medical technology company that specializes in advanced imaging solutions for assessing and monitoring organ health, particularly the liver. Their flagship product, LiverMultiScan, and other offerings like CoverScan, utilize AI-driven software to extract quantitative biomarkers from MRI data, aiming to provide non-invasive diagnostics and improve clinical decision-making. While their products are recognized for their innovative approach to quantifying disease activity and potentially reducing the need for invasive procedures like liver biopsies, employee reviews indicate significant issues with management, work-life balance, and company culture.

Overall: Mixed

Strengths

  • Innovative AI-driven quantitative MRI solutions for organ health assessment.
  • Products like LiverMultiScan can potentially reduce the need for invasive procedures like liver biopsies.
  • Offers non-invasive diagnostics for early detection, diagnosis, and targeted treatment of chronic systemic diseases.
  • Good company perks such as gym discounts and private health insurance.
  • Collaborative environment and friendly colleagues (mentioned in an internship review).
  • Good opportunities for interns to learn.

Limitations

  • Poor management and inexperienced leadership.
  • Toxic company culture.
  • Lack of work-life balance.
  • Very little feedback from management, often only to find blame.
  • Non-existent promotion process.
  • Some senior management members are unwilling to provide guidance or tasks to interns.

Based on reviews from: Indeed.com, YesPress, AuntMinnie, Medical Technology Enterprise Consortium (MTEC), Instagram, PharmaTimes

Last updated: 2026-10-17

Videos

News, demos, and interviews about Perspectum.

Loading videos...

Videos load interactively. If none appear, search YouTube for Perspectum →

View all on YouTube

Press & Coverage

King's College London
Perspectum partners with London Institute for Healthcare Engineering to Advance AI-Powered Medical Imaging Solutions
Perspectum announced a partnership with the London Institute for Healthcare Engineering (LIHE) to accelerate the translation of innovative imaging solutions for metabolic disease and cancer from research to patient care, including opening a new London office within LIHE.
2025-06
Business Wire
Perspectum Appoints Warren Cresswell as Chief Executive Officer
Perspectum announced the appointment of Warren Cresswell as Chief Executive Officer, bringing over 25 years of experience in diagnostics, pharmaceuticals, medical devices, and laboratory services.
2026-09
Perspectum
FDA Grants Clearance to Perspectum’s CoverScan – A New Platform-Based Tool to Assess Multiple Organs in One MRI Scan
The FDA granted 510(k) clearance to Perspectum's CoverScan, a noninvasive multiparametric advanced cloud-based software suite for comprehensive assessments of six organs.
2022-05
MedCity News
Perspectum Completes $55M Series C to Improve Metabolic Disease Diagnosis
Perspectum announced the second close of its $55 million Series C funding round, securing an additional $19 million investment led by Oppenheimer, bringing its total funding to approximately $140 million.
2023-03
Fierce Biotech
Perspectum’s liver-scanning software scores FDA clearance for planning cancer surgeries
Perspectum secured FDA 510(k) clearance for its Hepatica software, which uses MRI scans to guide cancer treatment and tumor removal, and identify patients at higher risk of poor surgical outcomes.
2021-02
Imaging Technology News
FDA Clears Perspectum's MRCP+ Digital Biliary Tree Viewer
Perspectum Diagnostics received 510(k) clearance from the FDA for its MRCP+ advanced biliary visualization software, which uses quantitative MRI and AI algorithms for improved visualization and measurement of biliary structures.
2019-01
AuntMinnie.com
Perspectum Diagnostics gets FDA clearance for LiverMultiScan
Perspectum Diagnostics received FDA 510(k) clearance for its LiverMultiScan postprocessing software for MRI of the liver, allowing quantitative measurement of liver tissue to assist with diagnosing liver disease.
2017-11
Perspectum
Perspectum Closes $36M Financing Round co-led by Blue Venture Fund and HealthQuest Capital
Perspectum announced the completion of a $36 million financing round co-led by Blue Venture Fund and HealthQuest Capital, to drive commercialization of LiverMultiScan and expand its CRO business.
2020-04

Frequently Asked Questions

Perspectum specializes in quantitative MRI for comprehensive liver assessment, providing non-invasive measures of fat, inflammation, and fibrosis. Their technology, including LiverMultiScan, aids in the diagnosis, monitoring, and management of conditions such as NAFLD, NASH, PSC, and AIH, offering detailed insights beyond traditional imaging.
Perspectum's AI-driven quantitative MRI provides a holistic view of multi-organ health, which is crucial for conditions like diabetes and cancer. For diabetes, it can assess related organ damage, while for cancer, it can aid in treatment planning and monitoring by evaluating tumor response and potential organ toxicity.
Perspectum offers a specialized Long COVID solution, primarily through their quantitative MRI technology, to assess the multi-organ impact of the condition. This helps physicians understand and manage the diverse symptoms and organ impairments associated with Long COVID, providing objective data for personalized care.
As a CRO, Perspectum provides comprehensive support for clinical trials, including regulatory compliance, data management, and expert interpretation of their quantitative MRI data. They ensure their diagnostic solutions meet rigorous standards for accuracy and reliability in research settings.
Perspectum's pricing for diagnostic products and CRO services is typically tailored to the specific needs of the client or research project. They offer robust technical support for their platforms and actively seek partnerships with healthcare providers and research institutions to integrate their advanced diagnostic solutions.

Related Companies

A2z Radiology AI is a Boston-based medical imaging AI company that develops software for comprehensive CT interpretation, initially focusing on abdomen-pelvis CT scans. The company’s primary goal is to enhance diagnostic accuracy and efficiency in medical imaging for healthcare providers by leveraging artificial intelligence. Their flagship product, a2z-Unified-Triage, is FDA-cleared radiological computer-aided triage and notification […]

Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]

SOPHiA GENETICS is a healthcare AI company that has developed a cloud-native, AI-driven SaaS platform called SOPHiA DDM™. This platform is designed to enable hospitals, clinical laboratories, academic medical centers, and biopharmaceutical companies to analyze and interpret complex genomic, radiomic, and multimodal healthcare data. The company’s mission is to democratize data-driven medicine, providing actionable insights […]

NTL Healthcare is a South Korean AI-powered women’s health company specializing in cervical cancer screening and diagnostics. The company has a history dating back to 1996 when it first introduced an analog cervical cancer reading system, Cervicography, to Korea. Since then, NTL Healthcare has evolved its technology, developing the world’s first remote uterine cervical cancer […]

Lumonus is a healthcare technology company that specializes in AI-powered solutions for cancer care, particularly in radiation oncology. The company’s core offering is the Lumonus AI platform, a digital oncology system with AI-native clinical infrastructure designed to automate and orchestrate critical oncology workflows. This platform aims to enhance the quality and speed of care delivery […]

Qure.ai is a leading healthcare AI company that leverages deep learning and artificial intelligence to revolutionize medical imaging diagnostics and make healthcare more accessible and affordable globally. The company develops AI-powered solutions for interpreting X-rays and CT scans, addressing critical health needs in areas such as lung, musculoskeletal, cardiovascular, and neurocritical health. Their technology assists […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.